Literature DB >> 14716024

Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease.

Katharina Schindowski1, Tilmann Kratzsch, Jürgen Peters, Barbara Steiner, Silke Leutner, Natalie Touchet, Konrad Maurer, Christian Czech, Laurent Pradier, Lutz Frölich, Walter E Müller, Anne Eckert.   

Abstract

The identification of specific genetic (presenilin-1 [PS1] and amyloid precursor protein [APP] mutations) and environmental factors responsible for Alzheimer's disease (AD) has revealed evidence for a shared pathway of neuronal death. Moreover, AD-specific cell defects may be observed in many other nonneuronal cells (e.g., lymphocytes). Thus, lymphocytes may serve as a cellular system in which to study risk factors of sporadic, as well as genetic AD in vivo. The aim of our present study was to clarify whether lymphocytes bearing genetic or sporadic risk factors of AD share an increased susceptibility to cell death. Additionally we examined whether a cell typespecific vulnerability pattern was present and how normal aging, the main risk factor of sporadic AD, contributes to changes in susceptibility to cell death. Here, we report that lymphocytes affected by sporadic or genetic APP and PS1 AD risk factors share an increased vulnerability to cell death and exhibit a similar cell type-specific pattern, given that enhanced vulnerability was most strongly developed in the CD4+ T-cell subtype. In this paradigm, sporadic risk factors revealed the highest impact on cell type-specific sensitivity of CD4+ T cells to apoptosis. In contrast, normal aging results in an increased susceptibility to apoptosis of both, CD4+ and CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14716024     DOI: 10.1385/NMM:4:3:161

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  55 in total

1.  The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia.

Authors:  J Sulger; C Dumais-Huber; R Zerfass; F A Henn; J B Aldenhoff
Journal:  Biol Psychiatry       Date:  1999-03-15       Impact factor: 13.382

2.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

Authors:  C Stadelmann; T L Deckwerth; A Srinivasan; C Bancher; W Brück; K Jellinger; H Lassmann
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice.

Authors:  O Wirths; G Multhaup; C Czech; V Blanchard; S Moussaoui; G Tremp; L Pradier; K Beyreuther; T A Bayer
Journal:  Neurosci Lett       Date:  2001-06-22       Impact factor: 3.046

4.  Immune ageing and Alzheimer's disease.

Authors:  M Hartwig
Journal:  Neuroreport       Date:  1995-06-19       Impact factor: 1.837

5.  Admission criteria for immunogerontological studies in man: the SENIEUR protocol.

Authors:  G J Ligthart; J X Corberand; C Fournier; P Galanaud; W Hijmans; B Kennes; H K Müller-Hermelink; G G Steinmann
Journal:  Mech Ageing Dev       Date:  1984-11       Impact factor: 5.432

6.  Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.

Authors:  K J Ivins; P L Thornton; T T Rohn; C W Cotman
Journal:  Neurobiol Dis       Date:  1999-10       Impact factor: 5.996

7.  Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

Authors:  Patrizia Mecocci; M Cristina Polidori; Antonio Cherubini; Tiziana Ingegni; Paola Mattioli; Marco Catani; Patrizia Rinaldi; Roberta Cecchetti; Wilhelm Stahl; Umberto Senin; M Flint Beal
Journal:  Arch Neurol       Date:  2002-05

8.  In situ hybridization analysis of presenilin 1 mRNA in Alzheimer disease and in lesioned rat brain.

Authors:  K Page; R Hollister; R E Tanzi; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

9.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

Review 10.  Mechanism and biological significance of CD4-mediated cytotoxicity.

Authors:  S Hahn; R Gehri; P Erb
Journal:  Immunol Rev       Date:  1995-08       Impact factor: 12.988

View more
  10 in total

1.  Prolonged exercise does not cause lymphocyte DNA damage or increased apoptosis in well-trained endurance athletes.

Authors:  E M Peters; M Van Eden; N Tyler; A Ramautar; A A Chuturgoon
Journal:  Eur J Appl Physiol       Date:  2006-08-29       Impact factor: 3.078

2.  Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors:  Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal:  Neuromolecular Med       Date:  2007-10-26       Impact factor: 3.843

3.  Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease.

Authors:  C Frey; A Bonert; T Kratzsch; G Rexroth; W Rösch; F Müller-Spahn; K Maurer; W E Müller; A Eckert
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

Review 4.  Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Authors:  Kristina Leuner; Kathrin Schulz; Tanja Schütt; Johannes Pantel; David Prvulovic; Virginie Rhein; Egemen Savaskan; Christian Czech; Anne Eckert; Walter E Müller
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

5.  PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients.

Authors:  Milena Damjanac; Guylène Page; Stéphanie Ragot; Guillaume Laborie; Roger Gil; Jacques Hugon; Marc Paccalin
Journal:  J Cell Mol Med       Date:  2009-02-04       Impact factor: 5.295

6.  Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.

Authors:  Joanna Wojsiat; Katarzyna Laskowska-Kaszub; Carolina Alquézar; Emilia Białopiotrowicz; Noemi Esteras; Mykola Zdioruk; Angeles Martin-Requero; Urszula Wojda
Journal:  Mol Neurobiol       Date:  2016-09-19       Impact factor: 5.590

7.  CA-30, an oligosaccharide fraction derived from Liuwei Dihuang decoction, ameliorates cognitive deterioration via the intestinal microbiome in the senescence-accelerated mouse prone 8 strain.

Authors:  Jianhui Wang; Xi Lei; Zongjie Xie; Xiaorui Zhang; Xiaorui Cheng; Wenxia Zhou; Yongxiang Zhang
Journal:  Aging (Albany NY)       Date:  2019-06-03       Impact factor: 5.682

Review 8.  PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease.

Authors:  Milena Morel; Julien Couturier; Claire Lafay-Chebassier; Marc Paccalin; Guylène Page
Journal:  J Cell Mol Med       Date:  2009-07-07       Impact factor: 5.310

9.  LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1ΔE9 transgenic mice.

Authors:  Jian-Hui Wang; Xi Lei; Xiao-Rui Cheng; Xiao-Rui Zhang; Gang Liu; Jun-Ping Cheng; Yi-Ran Xu; Ju Zeng; Wen-Xia Zhou; Yong-Xiang Zhang
Journal:  Alzheimers Res Ther       Date:  2016-12-13       Impact factor: 6.982

10.  Sex-associated differences in mitochondrial function in human peripheral blood mononuclear cells (PBMCs) and brain.

Authors:  C Silaidos; U Pilatus; R Grewal; S Matura; B Lienerth; J Pantel; G P Eckert
Journal:  Biol Sex Differ       Date:  2018-07-25       Impact factor: 5.027

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.